文献速递心血管MR

COVID-19患者的心血管磁共振应用

Cardiovascular Magnetic Resonance for Patients With COVID-19.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-10-13

本文综述了心血管磁共振(CMR)在COVID-19患者中的应用。COVID-19相关心肌损伤可由缺血、炎症或心肌炎引起,CMR是评估心脏功能、结构和组织特征的无创参考标准。研究显示,住院康复患者中CMR异常率为26%-60%,包括功能受损、心肌组织异常、晚期钆增强或心包异常;运动员中可检测到心肌炎样异常;儿童多系统炎症综合征相关心肌炎和冠状动脉瘤可用CMR评估。本文还提供了临床使用建议。

要点

  • CMR是评估COVID-19患者心脏功能、结构和组织特征的无创参考标准。
  • 住院康复患者中CMR异常率为26%-60%,包括功能受损、心肌组织异常、晚期钆增强或心包异常。
  • 儿童多系统炎症综合征相关心肌炎和冠状动脉瘤可用CMR评估。

关键影像表现/征象

  • 住院康复患者中CMR异常率为26%-60%,包括功能受损、心肌组织异常、晚期钆增强或心包异常。
  • 运动员COVID-19后CMR可检测到心肌炎样异常。
  • 儿童多系统炎症综合征在感染后2-6周发生,相关心肌炎和冠状动脉瘤可用CMR评估。

临床应用与阅片要点

  • 对COVID-19急性症状或康复期患者,可考虑使用CMR评估心肌损伤和心功能障碍。
  • 注意COVID-19相关心肌炎可能不常见,但心血管组织病理学发现报告率高达48%,需关注长期心肌损伤。

局限性

  • 对COVID-19相关心血管受累的认识不完整。
  • 多项研究正在进行中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

COVID-19 is associated with myocardial injury caused by ischemia, inflammation, or myocarditis. Cardiovascular magnetic resonance (CMR) is the noninvasive reference standard for cardiac function, structure, and tissue composition. CMR is a potentially valuable diagnostic tool in patients with COVID-19 presenting with myocardial injury and evidence of cardiac dysfunction. Although COVID-19-related myocarditis is likely infrequent, COVID-19-related cardiovascular histopathology findings have been reported in up to 48% of patients, raising the concern for long-term myocardial injury. Studies to date report CMR abnormalities in 26% to 60% of hospitalized patients who have recovered from COVID-19, including functional impairment, myocardial tissue abnormalities, late gadolinium enhancement, or pericardial abnormalities. In athletes post-COVID-19, CMR has detected myocarditis-like abnormalities. In children, multisystem inflammatory syndrome may occur 2 to 6 weeks after infection; associated myocarditis and coronary artery aneurysms are evaluable by CMR. At this time, our understanding of COVID-19-related cardiovascular involvement is incomplete, and multiple studies are planned to evaluate patients with COVID-19 using CMR. In this review, we summarize existing studies of CMR for patients with COVID-19 and present ongoing research. We also provide recommendations for clinical use of CMR for patients with acute symptoms or who are recovering from COVID-19.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Petersen SE, Friedrich MG, Leiner T, et al. Cardiovascular Magnetic Resonance for Patients With COVID-19. JACC Cardiovasc Imaging. 2021. PMID: 34656482. doi:10.1016/j.jcmg.2021.08.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。